Nafisah B Atako

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

Katrina M. Pollock, Hannah M. Cheeseman, Alexander J. Szubert et al. · EClinicalMedicine · 2022 · 162 citations · Full text

Pharmacy, Biotechnology, Immunology +16

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols

Francesca Schiavone, Riya Bathia, Krishna Letchemanan et al. · Trials · 2019 · 62 citations · Full text

Medicine, Biostatistics, Clinical Data Management +15

Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial

Ken M. Kunisaki, Dennis E. Niewoehner, Gary Collins et al. · The Lancet Respiratory Medicine · 2016 · 43 citations · Full text

Public Health, Pharmacotherapy, Pulmonary Function Testing +9

Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial

Clare Gilson, Fiona C. Ingleby, Duncan C. Gilbert et al. · JCO Precision Oncology · 2020 · 34 citations · Full text

Medicine, Oncology, Urology +17

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Emily Grist, Peter Dutey‐Magni, Marina Parry et al. · Cell · 2025 · 21 citations · Full text

Medicine, Cancer Biology, Oncology +17